MIT, Harvard Target Cardiovascular Disease with Nanoparticles

Read original story

MIT, Harvard Target Cardiovascular Disease with Nanoparticles

Description Researchers from the Massachusetts Institute of Technology and Harvard Medical School have built targeted nanoparticles that can cling to artery walls and slowly release medicine, an advance that potentially provides an alternative to drug-releasing stents in some patients with cardiovascular disease.
Imported on 19 Jan 2010, 22:37
Feed Name Eureka Alert
Feed URL http://www.eurekalert.org/rss/nanotechnology.xml
This RSS news item comes from another site. NanoScienceWorks and the Taylor and Francis Group are not responsible for the content of that site.
© NanoScienceWorks - Made possible by an endowment from Taylor & Francis Group.
For the best viewing experience we recommend Firefox 2+ or Internet Explorer 7+

Developed by Zentraal, Inc.